AML Paradigm Shift: Doctors Welcome Many New Approvals And Approaches

This year's ASH meeting reflected a peak of development success, with many new approvals and many more in the pipeline.

SC1812_Disruption_788079109_1200.jpg

More from Clinical Trials

More from R&D